An animal experiment found that the targeted deletion of YKL-40 suppressed glial phagocytic activation and promoted amyloid accumulation in a mouse APP/PS1 model of Alzheimer's disease [23]. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.